SenesTech, Inc. (SNES)
NASDAQ
Market Cap
$3.08M
Sector
Basic Materials
Industry
Chemicals—Specialty
Rank in Sector
141 of 149
Rank in Industry
52 of 52
Largest Insider Buys in Sector
SNES Stock Price History Chart
SNES Stock Performance
About SenesTech, Inc.
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Insider Activity of SenesTech, Inc.
Over the last 12 months, insiders at SenesTech, Inc. have bought $0 and sold $0 worth of SenesTech, Inc. stock.
On average, over the past 5 years, insiders at SenesTech, Inc. have bought $228,765 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 50,000 shares for transaction amount of $77,095 was made by Leach Jacob Steven (director) on 2021‑08‑18.
List of Insider Buy and Sell Transactions, SenesTech, Inc.
| 2021-08-18 | director | 50,000 0.4216% | $1.54 | $77,095 | -44.80% | |||
| 2021-08-17 | director | 50,000 0.4036% | $1.50 | $74,785 | -44.35% | |||
| 2021-08-16 | director | 50,000 0.4177% | $1.54 | $76,885 | -42.93% | |||
| 2019-10-21 | Sale | Chief Scientific Officer | 6,000 0.0242% | $0.83 | $4,980 | -86.20% | ||
| 2019-10-02 | Sale | Pres. & Chief Research Officer | 6,000 0.0246% | $0.93 | $5,575 | -86.21% | ||
| 2019-08-15 | Sale | Pres. & Chief Research Officer | 20,000 0.0697% | $1.21 | $24,100 | -82.49% | ||
| 2019-08-15 | Sale | Chief Scientific Officer | 20,000 0.0686% | $1.19 | $23,734 | -82.49% | ||
| 2019-08-14 | Sale | Pres. & Chief Research Officer | 20,000 0.0678% | $1.18 | $23,622 | -82.32% | ||
| 2019-08-14 | Sale | Chief Scientific Officer | 20,000 0.071% | $1.24 | $24,756 | -82.32% | ||
| 2019-07-16 | CEO | 696,296 2.5151% | $1.35 | $940,000 | -60.81% | |||
| 2018-08-13 | director | 11,000 0.0594% | $1.15 | $12,650 | -10.78% | |||
| 2018-06-21 | Sale | CEO & Chief Scientific Officer | 12,000 0.0741% | $2.13 | $25,560 | -55.93% | ||
| 2017-12-21 | Sale | CEO & Chief Scientific Officer | 6,000 0.0362% | $0.67 | $4,026 | +6.62% | ||
| 2017-12-04 | Sale | Pres. & Chief Research Officer | 6,000 0.0389% | $0.82 | $4,921 | -5.30% | ||
| 2017-11-24 | director | 1,700 0.0103% | $0.90 | $1,525 | -18.40% | |||
| 2017-11-21 | Sale | CEO & Chief Scientific Officer | 6,000 0.0365% | $0.89 | $5,363 | -16.85% | ||
| 2017-11-02 | Sale | Pres. & Chief Research Officer | 6,000 0.0359% | $2.72 | $16,339 | -72.72% | ||
| 2017-10-20 | Sale | CEO & Chief Scientific Officer | 6,000 0.0346% | $1.52 | $9,126 | -52.76% | ||
| 2017-10-03 | Sale | Pres. & Chief Research Officer | 6,000 0.0363% | $1.97 | $11,808 | -59.68% | ||
| 2017-09-22 | Sale | CEO & Chief Scientific Officer | 6,000 0.0556% | $1.79 | $10,740 | -56.15% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.